ID

30355

Descrizione

An Study of Patients With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Patients Who Take R-CHOP Only; ODM derived from: https://clinicaltrials.gov/show/NCT00451178

collegamento

https://clinicaltrials.gov/show/NCT00451178

Keywords

versioni (3)
  1. 29/05/18 29/05/18 -
  2. 29/05/18 29/05/18 -
  3. 29/05/18 29/05/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

29 maggio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Lymphoma NCT00451178

Inglese

Eligibility Lymphoma NCT00451178

1 moduli  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00451178
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must:
Descrizione

Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
1. have a histologically confirmed diagnosis of dlbcl based on the world health organization classification (harris et al. 1999) at the time of original diagnosis. pathology must be reviewed and confirmed prior to enrollment at the investigational site where the patient is entered. patients with a prior history of an indolent lymphoma or a histological diagnosis of follicular grade 3 lymphoma will not be eligible for enrollment.
Descrizione

ID.2

Tipo di dati

boolean

2. have received no prior chemotherapy.
Descrizione

Prior Chemotherapy Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0332197
3. have an ipi score > or = to 2 at time of original diagnosis.
Descrizione

IPI

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1512894
4. have a performance status of 0, 1, or 2 on the eastern cooperative oncology group (ecog) scale.
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
5. have adequate organ function as follows:
Descrizione

Organ function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678852
hepatic: total bilirubin < or = to 1.5 times the upper limit of normal (x uln); alanine transaminase (alt) and aspartate transaminase (ast) < or = to 1.5 x uln, (≤5 x uln, if liver involvement).
Descrizione

Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Liver Involvement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
UMLS CUI [5,1]
C0023884
UMLS CUI [5,2]
C1314939
renal: serum creatinine < or = to 1.5 x uln
Descrizione

Renal function | Creatinine measurement, serum

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
adequate bone marrow reserve: platelets > or = to 75 x 10 to the ninth/l, absolute neutrophil count (anc) > or = to 1.0 x 10 to the ninth/l, unless there is bone marrow involvement.
Descrizione

Bone Marrow Mature Neutrophils Present Adequate | Platelet Count measurement | Absolute neutrophil count | Exception Bone Marrow Involvement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C1708947
UMLS CUI [1,3]
C0205411
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0948762
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0005953
UMLS CUI [4,3]
C1314939
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients must not:
Descrizione

Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
6. have received treatment within the last 30 days with a drug (not including enzastaurin) that has not received regulatory approval for any indication at the time of study entry.
Descrizione

Drugs, Non-Prescription | Exception Enzastaurin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013231
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1327830
7. are receiving concurrent administration of any other systemic anticancer therapy.
Descrizione

Cancer treatment Systemic

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205373
8. are pregnant or breastfeeding.
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
9. are unable to swallow tablets.
Descrizione

Lacking Able to swallow Tablets

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C2712086
UMLS CUI [1,3]
C0039225
10. are unable to discontinue use of carbamazepine, phenobarbital, and phenytoin at least 14 days prior to study enrollment.
Descrizione

Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006949
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0031412
UMLS CUI [2,2]
C1444662
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C0031507
UMLS CUI [3,2]
C1444662
UMLS CUI [3,3]
C1299582
Ritorna all'inizio della pagina

Similar models

Eligibility Lymphoma NCT00451178

1 moduli
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00451178
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Criteria Fulfill
Item
patients must:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
ID.2
Item
1. have a histologically confirmed diagnosis of dlbcl based on the world health organization classification (harris et al. 1999) at the time of original diagnosis. pathology must be reviewed and confirmed prior to enrollment at the investigational site where the patient is entered. patients with a prior history of an indolent lymphoma or a histological diagnosis of follicular grade 3 lymphoma will not be eligible for enrollment.
boolean
Prior Chemotherapy Absent
Item
2. have received no prior chemotherapy.
boolean
C1514457 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
IPI
Item
3. have an ipi score > or = to 2 at time of original diagnosis.
boolean
C1512894 (UMLS CUI [1])
ECOG performance status
Item
4. have a performance status of 0, 1, or 2 on the eastern cooperative oncology group (ecog) scale.
boolean
C1520224 (UMLS CUI [1])
Organ function
Item
5. have adequate organ function as follows:
boolean
C0678852 (UMLS CUI [1])
Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Liver Involvement
Item
hepatic: total bilirubin < or = to 1.5 times the upper limit of normal (x uln); alanine transaminase (alt) and aspartate transaminase (ast) < or = to 1.5 x uln, (≤5 x uln, if liver involvement).
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0023884 (UMLS CUI [5,1])
C1314939 (UMLS CUI [5,2])
Renal function | Creatinine measurement, serum
Item
renal: serum creatinine < or = to 1.5 x uln
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Bone Marrow Mature Neutrophils Present Adequate | Platelet Count measurement | Absolute neutrophil count | Exception Bone Marrow Involvement
Item
adequate bone marrow reserve: platelets > or = to 75 x 10 to the ninth/l, absolute neutrophil count (anc) > or = to 1.0 x 10 to the ninth/l, unless there is bone marrow involvement.
boolean
C0005953 (UMLS CUI [1,1])
C1708947 (UMLS CUI [1,2])
C0205411 (UMLS CUI [1,3])
C0032181 (UMLS CUI [2])
C0948762 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0005953 (UMLS CUI [4,2])
C1314939 (UMLS CUI [4,3])
Item Group
C0680251 (UMLS CUI)
Criteria Fulfill
Item
patients must not:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Drugs, Non-Prescription | Exception Enzastaurin
Item
6. have received treatment within the last 30 days with a drug (not including enzastaurin) that has not received regulatory approval for any indication at the time of study entry.
boolean
C0013231 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1327830 (UMLS CUI [2,2])
Cancer treatment Systemic
Item
7. are receiving concurrent administration of any other systemic anticancer therapy.
boolean
C0920425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
8. are pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Lacking Able to swallow Tablets
Item
9. are unable to swallow tablets.
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
Carbamazepine Discontinue Unable | Phenobarbital Discontinue Unable | Phenytoin Discontinue Unable
Item
10. are unable to discontinue use of carbamazepine, phenobarbital, and phenytoin at least 14 days prior to study enrollment.
boolean
C0006949 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0031412 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C0031507 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial